JP2024530023A5 - - Google Patents

Info

Publication number
JP2024530023A5
JP2024530023A5 JP2024506879A JP2024506879A JP2024530023A5 JP 2024530023 A5 JP2024530023 A5 JP 2024530023A5 JP 2024506879 A JP2024506879 A JP 2024506879A JP 2024506879 A JP2024506879 A JP 2024506879A JP 2024530023 A5 JP2024530023 A5 JP 2024530023A5
Authority
JP
Japan
Prior art keywords
polypeptide
mutation
aav
seq
vector system
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506879A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024530023A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074611 external-priority patent/WO2023015297A1/en
Publication of JP2024530023A publication Critical patent/JP2024530023A/ja
Publication of JP2024530023A5 publication Critical patent/JP2024530023A5/ja
Pending legal-status Critical Current

Links

JP2024506879A 2021-08-05 2022-08-05 操作された筋肉標的化組成物 Pending JP2024530023A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163230046P 2021-08-05 2021-08-05
US63/230,046 2021-08-05
PCT/US2022/074611 WO2023015297A1 (en) 2021-08-05 2022-08-05 Engineered muscle targeting compositions

Publications (2)

Publication Number Publication Date
JP2024530023A JP2024530023A (ja) 2024-08-14
JP2024530023A5 true JP2024530023A5 (https=) 2025-08-14

Family

ID=85156332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506879A Pending JP2024530023A (ja) 2021-08-05 2022-08-05 操作された筋肉標的化組成物

Country Status (7)

Country Link
US (1) US20250090688A1 (https=)
EP (1) EP4381078A4 (https=)
JP (1) JP2024530023A (https=)
CN (1) CN118076743A (https=)
AU (1) AU2022324116A1 (https=)
CA (1) CA3230479A1 (https=)
WO (1) WO2023015297A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240095539A (ko) 2021-10-08 2024-06-25 디노 테라퓨틱스, 인코포레이티드 캡시드 변이체 및 이의 사용 방법
WO2024173802A2 (en) * 2023-02-17 2024-08-22 Biogen Ma Inc. Rgd-containing peptides for delivering payloads
WO2024238807A2 (en) * 2023-05-16 2024-11-21 Affinia Therapeutics Inc. Recombinant aavs with improved tropism and specificity
CN121203037A (zh) * 2025-09-26 2025-12-26 北京因诺惟康医药科技有限公司 基于整合素改造的特异性靶向心脏及肌肉的aav9优势突变体

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020368539A1 (en) * 2019-10-16 2022-04-28 Massachusetts Institute Of Technology Engineered muscle targeting compositions
KR20230053591A (ko) * 2020-07-22 2023-04-21 더 브로드 인스티튜트, 인코퍼레이티드 조작된 근육 표적화 조성물

Similar Documents

Publication Publication Date Title
JP2023534999A5 (https=)
JP2022551986A5 (https=)
JP2024530023A5 (https=)
JP2025500347A5 (https=)
JP6174318B2 (ja) アデノ随伴ウイルス構築物を含んでなるコンダクティング気道細胞を標的とするための組成物
JP2024095717A5 (https=)
JP2024009857A5 (https=)
JP2023524061A5 (https=)
JP2024099770A5 (https=)
JP2022529631A5 (https=)
JP2021512649A5 (https=)
IL273261B2 (en) Adeno-associated virus variant capsids and methods of using them
JP2022547197A5 (https=)
JP2023514242A5 (https=)
JP7541027B2 (ja) 筋肉発現のためのハイブリッドプロモーター
JP2023534037A5 (https=)
JP2022531809A5 (https=)
JP2021533805A5 (https=)
JP2023537358A5 (https=)
JP2021520837A5 (https=)
WO2020142714A1 (en) Aav expression cassette and aav vectors comprising the same
JP2023500793A5 (https=)
JP2022533448A5 (https=)
JP2021534766A5 (https=)
EP4717715A1 (en) Adeno-associated virus capsid protein, adeno-associated virus containing same, vector and use thereof